Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Alliqua enters into distribution agreement with Carolon Health Care Products

Alliqua Inc., a biomedical company offering a suite of drug delivery technologies and wound healing solutions, has entered into an agreement with Carolon Health Care Products through which it will gain both new sales distribution pathways and established customers.

26 Sep 2013

Ampio Pharmaceuticals announces financing transaction of $25 million

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a financing transaction that will provide $25 million in gross proceeds to the Company. The financing is a registered direct placement of common stock of the Company.

26 Sep 2013

FDA awards grants to boost development, availability of medical devices for children

The U.S. Food and Drug Administration today announced it has awarded seven grants totaling more than $3.5 million to various pediatric device consortia to boost the development and availability of medical devices for children.

26 Sep 2013

Engineered nanomaterials inhalation negatively impacts gestational development in animal models

After a decade of rapidly growing industrial use, unimaginably tiny particles surround us everywhere, every day, in everything we do. Used in the manufacturing of cosmetics, clothing, paints, food, drug delivery systems and many other familiar products we all use daily, little is known about the effects these materials have on health.

25 Sep 2013

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.

24 Sep 2013

UNC receives grants from FDA and NIH to establish Tobacco Centers of Regulatory Science

The University of North Carolina at Chapel Hill received two separate grants from the U.S. Food and Drug Administration and the National Institutes of Health today as part of an on-going interagency partnership. UNC will house two of 14 Tobacco Centers of Regulatory Science, which are receiving a total of up to $53 million for tobacco-related research in fiscal year 2013.

21 Sep 2013

FDA announces final rule for UDI system to identify medical devices

Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.

21 Sep 2013

SeraCare Life Sciences announces expansion of R&D facilities in Milford, Massachusetts

SeraCare Life Sciences, a manufacturer of life sciences tools, bulk plasma, and quality controls for diagnostic companies and clinical laboratories, announced an expansion of its research and manufacturing facilities at its Milford, Massachusetts headquarters.

21 Sep 2013

New research may help in regulation of tobacco products to protect public health

UC San Francisco will receive a five-year, $20 million grant as part of a first-of-its-kind tobacco science regulatory program by the U.S. Food and Drug Administration and the National Institutes of Health.

21 Sep 2013

FDA, NIH awarded $53 million to create 14 Tobacco Centers of Regulatory Science

The U.S. Food and Drug Administration and the National Institutes of Health today, as part of an on-going interagency partnership, have awarded a total of up to $53 million to fund tobacco-related research in fiscal year 2013 to create 14 Tobacco Centers of Regulatory Science.

20 Sep 2013

Uthealth receives funds to establish Tobacco Center of Regulatory Science

The University of Texas School of Public Health has received $20 million in funding from the United States Food and Drug Administration (FDA) and the National Institutes of Health (NIH) today as part of an ongoing interagency partnership.

20 Sep 2013

Orbeshield Earns Soligenix Up To $26.3M From BARDA

...

19 Sep 2013

BARDA Exercises $6M Option For Aeolus' Acute Radiation Syndrome Drug

...

19 Sep 2013

Federal judge passes consent order against Shamrock Medical for distributing mislabeled drugs

The U.S. Food and Drug Administration announced today that federal judge Algenon L. Marbley of the Southern District of Ohio has approved a consent decree of permanent injunction against Shamrock Medical Solutions Group, LLC, of Lewis Center, Ohio, and four of its corporate officers and employees for continued drug manufacturing and labeling violations that resulted in the distribution of mislabeled drugs.

19 Sep 2013

Functional brain mapping and high speed physiology multiphoton system from Olympus

The Olympus FluoView® FVMPE-RS, a dedicated multiphoton microscope system, enables high-precision, ultra-fast scanning and stimulation, allowing researchers to see deep within specimens, take measurements at the highest speeds, and capture images even when working under the most demanding conditions.

From Evident Corporation - Life Sciences 17 Sep 2013

PRISYM ID releases new web-based solution to transform Label Lifecycle Management

PRISYM ID has launched a new solution – PRISYM 360, to transform global Label Lifecycle Management in the medical device industry through intelligent use of data.

17 Sep 2013

PRISYM ID launches new solution to transform global Label Lifecycle Management

PRISYM ID has launched a new solution - PRISYM 360, to transform global Label Lifecycle Management in the medical device industry through intelligent use of data.

17 Sep 2013

FDA issues import alert on drug products manufactured at Ranbaxy's facility in Mohali, India

The U.S. Food and Drug Administration today issued an import alert under which U.S. officials may detain at the U.S. border drug products manufactured at Ranbaxy Laboratories, Ltd.'s facility in Mohali, India.

17 Sep 2013

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

The U.S. Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.

17 Sep 2013

Sigma-Tau Pharmasource, Aradigm Ink Manufacturing Deal For Respiratory Disease Treatment

...

16 Sep 2013

Manufacturing News and Research

Further Reading

Alliqua enters into distribution agreement with Carolon Health Care Products

Ampio Pharmaceuticals announces financing transaction of $25 million

FDA awards grants to boost development, availability of medical devices for children

Engineered nanomaterials inhalation negatively impacts gestational development in animal models

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

UNC receives grants from FDA and NIH to establish Tobacco Centers of Regulatory Science

FDA announces final rule for UDI system to identify medical devices

SeraCare Life Sciences announces expansion of R&D facilities in Milford, Massachusetts

New research may help in regulation of tobacco products to protect public health

FDA, NIH awarded $53 million to create 14 Tobacco Centers of Regulatory Science

Uthealth receives funds to establish Tobacco Center of Regulatory Science

Orbeshield Earns Soligenix Up To $26.3M From BARDA

BARDA Exercises $6M Option For Aeolus' Acute Radiation Syndrome Drug

Federal judge passes consent order against Shamrock Medical for distributing mislabeled drugs

Functional brain mapping and high speed physiology multiphoton system from Olympus

PRISYM ID releases new web-based solution to transform Label Lifecycle Management

PRISYM ID launches new solution to transform global Label Lifecycle Management

FDA issues import alert on drug products manufactured at Ranbaxy's facility in Mohali, India

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

Sigma-Tau Pharmasource, Aradigm Ink Manufacturing Deal For Respiratory Disease Treatment

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News